Westermann and colleagues define four subtypes of neuroblastoma based on super-enhancer profiles in primary patient samples, which could be linked to distinct clinical outcomes and cell identity characteristics.
- Moritz Gartlgruber
- Ashwini Kumar Sharma
- Frank Westermann